APPROACH TO TREATING REFRACTORY VASOPLEGIC SHOCK

Background. Vasoplegic shock is characterized by low systemic vascular resistance in the setting of a high-output state. When severe enough, it ...

Refractory Shock - StatPearls - NCBI Bookshelf

Management of refractory shock involves treating the cause and restoring organ perfusion with fluid resuscitation and vasopressors. This activity outlines the ...

Vasoplegic Syndrome and Noncatecholamine Therapies - NCBI

Treatment / Management · Vasopressin. When high doses of catecholamines are ineffective for maintaining blood pressure or result in adverse ...

A Systematic Approach to the Treatment of Vasoplegia Based on ...

In the same review, 55 of 115 patients in refractory shock treated with angiotensin II died.

Management of Refractory Vasodilatory Shock - ScienceDirect.com

Standard approaches to the initial management of shock include fluid resuscitation and initiation of norepinephrine. When these measures are inadequate to ...

A Systematic Approach to the Treatment of Vasoplegia Based on ...

22 In the same review, 55 of 115 patients in refractory shock treated with angiotensin II died.22 High-quality studies in cardiac surgery are absent ...

Approach to shock & refractory shock - EMCrit Project

MB seems to be a fairly safe therapy if appropriate caution is utilized surrounding drug-drug interactions, contraindications (listed above), ...

878: treatment of refractory vasoplegic shock with hydroxocobalamin ...

High dose vasopressor therapy has been the gold standard treatment, but can be associated with adverse effects. Hydroxocobalamin and methylene blue may be ...

Vasoplegic syndrome following cardiothoracic surgery—review of ...

Treatment of this syndrome is usually limited to the initiation of vasopressors to maintain adequate perfusion pressures via the targeting of a ...

Severe Refractory Vasoplegic Shock Syndrome after OPCABG ...

Aggressive treatment is usually required, yet this process needs to be continuously tailored to the hemodynamic status of the patient. The pathophysiology of ...

Vasoplegic syndrome—the role of methylene blue - Oxford Academic

In cases where first-line therapy fails, the use of methylene blue seems to be a potent approach to refractory vasoplegia. The early use of ...

Vasoplegia: A Review | Methodist DeBakey Cardiovascular J

Treatment · Catecholamines. Patients with distributive shock are initially managed with volume expansion and administration of vasopressors like ...

Methylene blue for vasodilatory shock in the intensive care unit

Rescue therapy for vasoplegia refractory to catecholamines includes methylene blue (MB) which restores vascular tone. We hypothesized that (1) ...

Is intravenous hydroxocobalamin an effective treatment for ...

For refractory shock-associated vasoplegia, numerous rescue or adjunctive agents have been evaluated including methylene blue or thiamine.4.

APPROACH TO TREATING REFRACTORY VASOPLEGIC SHOCK

Request PDF | On Apr 1, 2024, Tatiana Henriksson and others published EXPLORING HIGH-DOSE HYDROXOCOBALAMIN: APPROACH TO TREATING REFRACTORY ...

33. Vasoplegia Syndrome Management Post Cardiac Surgery

The exogenous administration of vasopressin has been shown to have efficacy in improving the blood pressure in patients with refractory shock who are ...

Management of Refractory Vasodilatory Shock - CHEST Journal

Standard approaches to the initial management of shock include fluid resuscitation and initiation of norepinephrine. When these measures are ...

Vasoplegia - an overview | ScienceDirect Topics

Guideline-based therapy includes stepwise escalation of infusions starting with norepinephrine, then adding vasopressin, then a single dose of methylene blue.

Vasoplegic Syndrome and Anaesthesia: A Narrative Review

VS management is based on restoring vascular tone. For this reason, vasoactive agents are preferred first in the treatment. These agents act on ...

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive ...

Treatment usually includes addressing the underlying cause and the provision of supportive care including intravenous fluids and vasoactive ...